- Home
- |
- Intelligence Center
- |
- News
News
Astrea Bioseparations introduces Nereus LentiHERO®, a fit-for-purpose solution for lentiviral vector purification
Published: 28 September 2022
Astrea Bioseparations joins Biotage, enabling groundbreaking chromatography solutions
Published: 01 June 2023
Astrea Bioseparations makes critical infrastructure investments in Cambridge, UK & Singapore
Published: 15 September 2021
Astrea Bioseparations acknowledges FDA approval of LIB Therapeutics’ LEROCHOL™
Published: 07 January 2026